News Room

27

Jul 21

Clinical Utility of ALK Fusion Detection by Liquid Biopsy

Clinical Utility of ALK Fusion Detection by Liquid Biopsy Cell-free DNA NGS detects common and novel ALK fusions in the...
Read More

25

Jun 21

How AI Might Boost Radiology Efficiency and Effectiveness

How AI Might Boost Radiology Efficiency and Effectiveness The CentricityTM Universal Viewer1 worklist provides indications for exams with AI Findings2...
Read More

22

Jun 21

Trending AI and Digital Solutions in Radiology—current adoption, applications and continuing developments

Trending AI and Digital Solutions in Radiology—current adoption, applications and continuing developments In the wake of the global COVID-19 pandemic,...
Read More

4

Jun 21

Cell-Free DNA Guided Targeted Therapy Leads to Better Survival in Advanced Non-Small Cell Lung Cancer

Cell-Free DNA Guided Targeted Therapy Leads to Better Survival in Advanced Non-Small Cell Lung Cancer MSK and Resolution Bioscience (a...
Read More

24

Mar 21

GE Healthcare Introduces StarGuide, a New Nuclear Medicine System to Help Advance Precision Health & Theranostics

GE Healthcare Introduces StarGuide, a New Nuclear Medicine System to Help Advance Precision Health & Theranostics GE Healthcare introduces StarGuide,...
Read More

17

Mar 21

Agilent Announces Cash Dividend of 19.4 Cents per Share

Agilent Announces Cash Dividend of 19.4 Cents per Share Agilent Technologies, Inc. (NYSE: A) today announced that a quarterly dividend...
Read More

9

Mar 21

Agilent Completes CE-IVD Registration of qRT-PCR In Vitro Diagnostic Kit for SARS-CoV-2 RNA Detection

Agilent Completes CE-IVD Registration of qRT-PCR In Vitro Diagnostic Kit for SARS-CoV-2 RNA Detection Agilent Technologies Inc. (NYSE: A) today...
Read More

9

Mar 21

Dr. Katharine Knobil Named Agilent’s First Chief Medical Officer

Dr. Katharine Knobil Named Agilent’s First Chief Medical Officer Agilent Technologies Inc. (NYSE: A), today announced that Dr. Katharine (Kate)...
Read More

2

Mar 21

Agilent to Acquire Resolution Bioscience, Strengthening Leadership Position in Cancer Diagnostics

Agilent to Acquire Resolution Bioscience, Strengthening Leadership Position in Cancer Diagnostics Resolution Bioscience is a fast-growing, innovative leader in next-generation...
Read More

22

Feb 21

Agilent PD-L1 IHC 22C3 pharmDx Receives Expanded FDA Approval in Non-small Cell Lung Cancer (NSCLC)

Agilent PD-L1 IHC 22C3 pharmDx Receives Expanded FDA Approval in Non-small Cell Lung Cancer (NSCLC) Agilent Technologies Inc. (NYSE: A)...
Read More